SENTYNL THERAPEUTICS, INC.
Sentynl Therapeutics, Inc. is a pharmaceutical company that provides treatment options for patients experiencing moderate to severe pain due to underlying diseases. The company acquires, develops, and commercializes prescription products. It provides healthcare professionals with treatment solutions that enable them to meet the needs of individual patients. Founded in 2014, Sentynl Therapeutics is based in Solana Beach, California.
SENTYNL THERAPEUTICS, INC.
Social Links:
Industry:
Health Care Health Diagnostics Pharmaceutical Therapeutics
Founded:
2014-01-01
Address:
Solana Beach, California, United States
Country:
United States
Website Url:
http://www.sentynl.com
Total Employee:
11+
Status:
Active
Contact:
877-767-2656
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Current Employees Featured
Founder
Official Site Inspections
http://www.sentynl.com
- Host name: 1030956.cloudwaysapps.com
- IP address: 159.223.132.34
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sentynl Therapeutics, Inc."
About Us - Sentynl Therapeutics, Inc.
Our Guiding Principles. Our goal is to provide novel biopharmaceutical medicines that extend, improve, or enhance the lives of people with rare diseases.See details»
Sentynl Therapeutics, Inc. - Crunchbase Company …
Sentynl Therapeutics is a U.S.-based biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases. The company was acquired by the Zydus Group in 2017. Sentynl’s experienced …See details»
The Menkes Foundation - Menkes, Charitable …
Dec 6, 2023 Sentynl now assumes full responsibility for the development and commercialization of CUTX-101. In 2021, Sentynl and Cyprium reported positive results from a safety and efficacy analysis of data integrated from two …See details»
Leadership - Sentynl Therapeutics, Inc.
Prior to joining Sentynl, Darren was Executive Director of Corporate and Business Development at Pacira Pharmaceuticals, ... most notably as the head of US operations and global marketing for an Israel-based organization, where they …See details»
Sentynl Therapeutics, Inc. - The Org
Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living …See details»
Sentynl Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Sentynl Therapeutics, Inc. of Solana Beach, CA. Get the latest business insights from Dun & Bradstreet.See details»
Sentynl Therapeutics Company Profile 2024: Valuation, Investors ...
Sentynl Therapeutics is headquartered in Solana Beach, CA. What is the size of Sentynl Therapeutics? Sentynl Therapeutics has 25 total employees. What industry is Sentynl …See details»
Working at Sentynl Therapeutics: 6 Reviews - Indeed
Reviews from Sentynl Therapeutics employees about Sentynl Therapeutics culture, salaries, benefits, work-life balance, management, job security, and more. ... A quality organization with …See details»
Sentynl Therapeutics, Inc. Overview - SignalHire
Sentynl Therapeutics, Inc. is a private company that has been in the industry for 11 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals areas. ... Organization …See details»
Sentynl Therapeutics, Inc. - Contacts, Employees, Board Members ...
Sentynl Therapeutics, Inc. has 8 current employee profiles, including Senior Vice President, General Counsel and Chief Compliance Officer Michael Hercz. Contacts Edit Contacts SectionSee details»
SENTYNL THERAPEUTICS, INC. - Zydus Life
Sentynl Therapeutics, Inc. Notes to Financial Statements 7 Note 1 - Organization and Description of Business Sentynl Therapeutics, Inc. (the Company, or STI) was formed as a Delaware …See details»
Sentynl Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Cosibelimab is currently in development at our partner company, Checkpoint Therapeutics (Nasdaq: CKPT) (“Checkpoint”).In December 2023, we completed the asset transfer of CUTX …See details»
Sentynl Therapeutics - Overview, News & Similar companies
Sentynl's highly experienced and knowledgeable management team has previously built multiple successful pharmaceutical companies. With a focus on commercialization, Sentynl looks to …See details»
Matt Heck - Co-Founder, President & Chief Executive Officer
Primary Organization . Sentynl Therapeutics, Inc. Location San Diego, California, United States; Regions Greater San Diego Area, West Coast ... Prior to Sentynl, Mr Heck co-founded Victory …See details»
Sentynl Therapeutics - Craft
Sentynl Therapeutics Announces Continued Availability of NULIBRY® (fosdenopterin) and the Launch of Sentynl Cares™ Patient Access Program. Apr 25, 2022 Fortress Biotech, Cyprium …See details»
Sentynl Therapeutics Inc., a wholly owned subsidiary of Zydus ...
Sentynl Therapeutics is a U.S.-based biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases. ... programs ranges from early science to …See details»
News and Events - Sentynl Therapeutics, Inc.
Sep 7, 2023 Zydus Americas had a 94% employee survey response rate and 90% of employees described the company as a great place to work. Solana Beach, CA, and Ahmedabad, India – …See details»
How Kyndryl’s CHRO led a corporate cultural transformation post …
2 days ago After technology services company Kyndryl separated from IBM, Maryjo Charbonnier was tasked with structuring a whole new organization for 80,000 workers. HR leader Maryjo …See details»
Portfolio - Sentynl Therapeutics, Inc.
Cyprium Therapeutics, Inc., with support from Sentynl, is developing CUTX-101 to restore copper homeostasis and maintain copper levels in patients with Menkes disease and related …See details»